{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:03:48Z","timestamp":1792253028616,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,4,8]],"date-time":"2012-04-08T00:00:00Z","timestamp":1333843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s10585-012-9477-1","type":"journal-article","created":{"date-parts":[[2012,4,8]],"date-time":"2012-04-08T07:31:43Z","timestamp":1333870303000},"page":"879-887","source":"Crossref","is-referenced-by-count":6,"title":["VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma"],"prefix":"10.1007","volume":"29","author":[{"given":"Alexander","family":"Schultze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Ben Batalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Riethdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bubenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Yekebas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Erbersdobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Reichelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina E.","family":"Effenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob R.","family":"Izbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Pantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Loges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,8]]},"reference":[{"key":"9477_CR1","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","volume":"358","author":"RS Kerbel","year":"2008","unstructured":"Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358:2039\u20132049","journal-title":"N Engl J Med"},{"key":"9477_CR2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","volume":"8","author":"LM Ellis","year":"2008","unstructured":"Ellis LM, Hicklin DJ (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev 8:579\u2013591","journal-title":"Nat Rev"},{"key":"9477_CR3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8:592\u2013603","journal-title":"Nat Rev Cancer"},{"key":"9477_CR4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nrc2524","volume":"8","author":"C Fischer","year":"2008","unstructured":"Fischer C, Mazzone M, Jonckx B et al (2008) FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev 8:942\u2013956","journal-title":"Nat Rev"},{"key":"9477_CR5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","volume":"9","author":"M Autiero","year":"2003","unstructured":"Autiero M, Waltenberger J, Communi D et al (2003) Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9:936\u2013943","journal-title":"Nat Med"},{"key":"9477_CR6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","volume":"8","author":"A Luttun","year":"2002","unstructured":"Luttun A, Tjwa M, Moons L et al (2002) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8:831\u2013840","journal-title":"Nat Med"},{"key":"9477_CR7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","volume":"8","author":"O Casanovas","year":"2005","unstructured":"Casanovas O, Hicklin DJ, Bergers G et al (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8:299\u2013309","journal-title":"Cancer Cell"},{"key":"9477_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2005.02.2574","volume":"24","author":"RJ Motzer","year":"2006","unstructured":"Motzer RJ, Michaelson MD, Redman BG et al (2006) Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 24:16\u201324","journal-title":"J Clin Oncol"},{"key":"9477_CR9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","volume":"131","author":"C Fischer","year":"2007","unstructured":"Fischer C, Jonckx B, Mazzone M et al (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131:463\u2013475","journal-title":"Cell"},{"key":"9477_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2004.05.020","volume":"213","author":"CN Chen","year":"2004","unstructured":"Chen CN, Hsieh FJ, Cheng YM et al (2004) The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett 213:73\u201382","journal-title":"Cancer Lett"},{"key":"9477_CR11","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.ejca.2005.07.022","volume":"41","author":"C Parr","year":"2005","unstructured":"Parr C, Watkins G, Boulton M et al (2005) Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer 41:2819\u20132827","journal-title":"Eur J Cancer"},{"key":"9477_CR12","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2004.050831","volume":"54","author":"SC Wei","year":"2005","unstructured":"Wei SC, Tsao PN, Yu SC et al (2005) Placenta growth factor expression is correlated with survival of patients with colorectal cancer. Gut 54:666\u2013672","journal-title":"Gut"},{"key":"9477_CR13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7819-3-68","volume":"3","author":"L Zhang","year":"2005","unstructured":"Zhang L, Chen J, Ke Y et al (2005) Expression of Placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance. World J Surg Oncol 3:68","journal-title":"World J Surg Oncol"},{"key":"9477_CR14","first-page":"239","volume":"6","author":"A Escudero-Esparza","year":"2009","unstructured":"Escudero-Esparza A, Martin TA, Davies ML et al (2009) PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance. Cancer Genomics Proteomics 6:239\u2013246","journal-title":"Cancer Genomics Proteomics"},{"key":"9477_CR15","first-page":"537","volume":"23","author":"A Escudero-Esparza","year":"2010","unstructured":"Escudero-Esparza A, Martin TA, Douglas-Jones A et al (2010) PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance. Oncol Rep 23:537\u2013544","journal-title":"Oncol Rep"},{"key":"9477_CR16","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1158\/1078-0432.CCR-08-2276","volume":"15","author":"S Loges","year":"2009","unstructured":"Loges S, Schmidt T, Carmeliet P (2009) \u201cAntimyeloangiogenic\u201d therapy for cancer by inhibiting PlGF. Clin Cancer Res 15:3648\u20133653","journal-title":"Clin Cancer Res"},{"key":"9477_CR17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cell.2009.01.020","volume":"136","author":"M Mazzone","year":"2009","unstructured":"Mazzone M, Dettori D, Leite de Oliveira R et al (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136:839\u2013851","journal-title":"Cell"},{"key":"9477_CR18","first-page":"365","volume":"132","author":"S Rozen","year":"2000","unstructured":"Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365\u2013386","journal-title":"Methods Mol Biol"},{"key":"9477_CR19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1158\/1078-0432.CCR-06-1324","volume":"13","author":"S Loges","year":"2007","unstructured":"Loges S, Clausen H, Reichelt U et al (2007) Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis. Clin Cancer Res 13:76\u201380","journal-title":"Clin Cancer Res"},{"key":"9477_CR20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611\u2013622","journal-title":"Clin Chem"},{"key":"9477_CR21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0901-5027(05)80490-4","volume":"24","author":"HJ Gath","year":"1995","unstructured":"Gath HJ, Heissler E, Hell B et al (1995) Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck region. Int J Oral Maxillofac Surg 24:351\u2013355","journal-title":"Int J Oral Maxillofac Surg"},{"key":"9477_CR22","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/jnci\/dji431","volume":"97","author":"JT Kaifi","year":"2005","unstructured":"Kaifi JT, Yekebas EF, Schurr P et al (2005) Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst 97:1840\u20131847","journal-title":"J Natl Cancer Inst"},{"key":"9477_CR23","first-page":"607","volume":"77","author":"HM Sowter","year":"1997","unstructured":"Sowter HM, Corps AN, Evans AL et al (1997) Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Laboratory investigation. J Tech Methods Pathol 77:607\u2013614","journal-title":"J Tech Methods Pathol"},{"key":"9477_CR24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/1541-7786.MCR-06-0141","volume":"5","author":"L Xu","year":"2007","unstructured":"Xu L, Jain RK (2007) Down-regulation of placenta growth factor by promoter hypermethylation in human lung and colon carcinoma. Mol Cancer Res 5:873\u2013880","journal-title":"Mol Cancer Res"},{"key":"9477_CR25","first-page":"3","volume":"16","author":"N Amaoka","year":"2006","unstructured":"Amaoka N, Saio M, Nonaka K et al (2006) Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma. Oncol Rep 16:3\u201310","journal-title":"Oncol Rep"},{"key":"9477_CR26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.0.CO;2-E","volume":"86","author":"T Andre","year":"2000","unstructured":"Andre T, Kotelevets L, Vaillant JC et al (2000) Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int J Cancer 86:174\u2013181","journal-title":"Int J Cancer"},{"key":"9477_CR27","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1158\/1078-0432.CCR-07-0414","volume":"13","author":"T Donnem","year":"2007","unstructured":"Donnem T, Al-Saad S, Al-Shibli K et al (2007) Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer Res 13:6649\u20136657","journal-title":"Clin Cancer Res"},{"key":"9477_CR28","doi-asserted-by":"crossref","unstructured":"Fragoso R, Igreja C, Clode N et al (2008) VEGF signaling on hematopoietic precursors restricts B-lymphoid commitment in vitro and in vivo. Exp Hematol 36(10):1329\u20131336","DOI":"10.1016\/j.exphem.2008.04.023"},{"key":"9477_CR29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.56.2.107","volume":"56","author":"MA Ghanem","year":"2003","unstructured":"Ghanem MA, van Steenbrugge GJ, Sudaryo MK et al (2003) Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma. J Clin Pathol 56:107\u2013113","journal-title":"J Clin Pathol"},{"key":"9477_CR30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0022-5347(05)67414-9","volume":"164","author":"D Hahn","year":"2000","unstructured":"Hahn D, Simak R, Steiner GE et al (2000) Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues. The Journal of urology 164:506\u2013510","journal-title":"The Journal of urology"},{"key":"9477_CR31","first-page":"5822","volume":"53","author":"KH Plate","year":"1993","unstructured":"Plate KH, Breier G, Millauer B et al (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53:5822\u20135827","journal-title":"Cancer Res"},{"key":"9477_CR32","first-page":"1719","volume":"28","author":"M Schmidt","year":"2008","unstructured":"Schmidt M, Voelker HU, Kapp M et al (2008) Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage. Anticancer Res 28:1719\u20131724","journal-title":"Anticancer Res"},{"key":"9477_CR33","first-page":"2811","volume":"17","author":"I Takanami","year":"1997","unstructured":"Takanami I, Tanaka F, Hashizume T et al (1997) Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res 17:2811\u20132814","journal-title":"Anticancer Res"},{"key":"9477_CR34","first-page":"3977","volume":"22","author":"H Kato","year":"2002","unstructured":"Kato H, Yoshikawa M, Miyazaki T et al (2002) Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. Anticancer Res 22:3977\u20133984","journal-title":"Anticancer Res"},{"key":"9477_CR35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00066-008-1850-2","volume":"184","author":"D Rades","year":"2008","unstructured":"Rades D, Golke H, Schild SE et al (2008) Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy. Strahlenther Onkol 184:416\u2013420","journal-title":"Strahlenther Onkol"},{"key":"9477_CR36","first-page":"845","volume":"20","author":"I Gockel","year":"2008","unstructured":"Gockel I, Moehler M, Frerichs K et al (2008) Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer. Oncol Rep 20:845\u2013850","journal-title":"Oncol Rep"},{"key":"9477_CR37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrc2375","volume":"8","author":"K Pantel","year":"2008","unstructured":"Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev 8:329\u2013340","journal-title":"Nat Rev"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-012-9477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-012-9477-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-012-9477-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T01:29:49Z","timestamp":1561598989000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-012-9477-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["9477"],"URL":"https:\/\/doi.org\/10.1007\/s10585-012-9477-1","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,8]]}}}